Screener
Halozyme Therapeutics HALO Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $9.28B.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
FAQ
- What is Halozyme Therapeutics's market capitalization?
- Halozyme Therapeutics (HALO) reported market capitalization of $9.28B in Q2 2026.
- How has Halozyme Therapeutics's market capitalization changed year-over-year?
- Halozyme Therapeutics's market capitalization increased by 39.8% year-over-year, from $6.64B to $9.28B.
- What is the long-term trend for Halozyme Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's market capitalization has grown at a 6.1% compound annual growth rate (CAGR), from $5.89B to $7.91B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Halozyme Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude